Phentermine

Quick links to important sections

Phentermine

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Phentermine

Quick Facts

Property Description
Active ingredient Phentermine Hydrochloride
Form Oral tablets, capsules, and extended-release capsules
Pharmacological class Sympathomimetic Amine, Anorectic Agent
Common use Short-term management of exogenous obesity
Origin Synthetic, substituted amphetamine structure

Defining Phentermine: A Sympathomimetic Anorectic Agent

Phentermine is a prescription-only anorectic agent used for the short-term support of weight management in adults. The fundamental chemical entity is the active ingredient, Phentermine Hydrochloride, which is classified pharmacologically as a sympathomimetic amine and a central nervous system (CNS) stimulant. This class of drugs is clinically recognized for its effects on appetite regulation. This compound is a synthetic drug, known scientifically as a substituted amphetamine, differentiating its structure and action from non-amphetamine stimulants. This identity is critical in its positioning as an adjunct therapy for individuals with obesity seeking to initiate significant dietary changes.

Composition, Forms, and General Purpose

Phentermine Hydrochloride is consistently delivered via the oral route and is available in several solid dosage forms, including standard immediate-release tablets, capsules, and extended-release capsules. The availability of both immediate-release (IR) and extended-release (ER) forms represents a key differentiating factor, allowing medical providers to tailor the release profile to specific patient needs. The drug is supplied either as a single-entity product or as a fixed-dose combination product alongside other therapeutic agents. The general therapeutic purpose of this medication is to aid in managing excessive weight associated with exogenous obesity. The medication's primary action is appetite suppression, which is a widely recognized mechanism for creating the necessary calorie deficit. This action helps patients maintain the dietary control required for effective weight loss when the medication is integrated into a comprehensive program of diet and exercise.

What side effects are possible with Phentermine?

Possible Side Effects and Safety Information

The officially documented safety profile for Phentermine, a sympathomimetic amine, is primarily characterized by adverse reactions across the Central Nervous System (CNS) and Cardiovascular systems. Classification as a Schedule IV controlled substance by regulatory authorities reflects the recognized risk of abuse and dependence.

Adverse events are often grouped by the affected system. CNS reactions include overstimulation, restlessness, insomnia, dizziness, and headache, while cardiovascular reactions may involve palpitation, tachycardia, and elevation of blood pressure. Gastrointestinal effects such as dry mouth and constipation are also commonly listed.

Classification of Serious Risks
Rare Cases: Regulatory documents note the occurrence of Primary Pulmonary Hypertension (PPH) and serious regurgitant cardiac valvular disease.
Serious Intoxication: Manifestations of chronic intoxication can involve psychosis.

Safety notes for specific populations are documented. Caution is required when used in older patients due to the higher likelihood of age-related changes in organ function. Use in patients with renal impairment requires caution, and it is contraindicated in those with End-Stage Renal Disease. The safety and effectiveness have not been established for the pediatric population.

Exposure-related patterns include the potential for the development of tolerance to the drug's effect over a few weeks. Furthermore, withdrawal effects, such as extreme fatigue and mental depression, may occur upon abrupt cessation following prolonged high-dosage administration. Co-administration with other weight loss agents is generally not recommended, and use with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated due to the risk of hypertensive crisis.

Overdose and Emergency Response

Overdose Scope

Property Description
Documented overdose presentations Acute intoxication is characterized by symptoms of CNS stimulation (restlessness, tremor, hyperreflexia, rapid respiration, confusion, assaultiveness, hallucinations, panic states) followed by fatigue and depression.
Physiological systems affected (as stated in label) Central Nervous System, Cardiovascular system (tachycardia, arrhythmia, hypertension/hypotension, circulatory collapse), and Gastrointestinal system (nausea, vomiting, diarrhea, abdominal cramps).
Dose-related or exposure-related factors Chronic intoxication is also documented, presenting with severe dermatoses, marked insomnia, irritability, hyperactivity, personality changes, and a severe manifestation of psychosis (clinically indistinguishable from schizophrenia).
Population-specific overdose notes The official labeling advises that the least amount feasible should be prescribed at one time to minimize the possibility of overdosage.
Emergency-response statements Management of acute intoxication is largely symptomatic and supportive, including gastric lavage and sedation with a barbiturate.
When immediate medical help is required Urgent medical attention is required for suspected overdosage due to the risk of severe outcomes like circulatory collapse, convulsions, and fatal poisoning.

Overdose Classifications (High-Level)

Classification Description
Severity classification Outcomes range from symptomatic CNS/Cardiovascular presentation to life-threatening effects, including convulsions and coma.
Regulatory basis Based on official FDA Prescribing Information.
Overdose-context constraints The regulatory text states that no specific antidote is known, though intravenous phentolamine is suggested for acute, severe hypertension, and acidification of the urine increases excretion.

Resulting Overdose Structure

Official overdose statements:

  • Overdosage is characterized by initial CNS hyper-stimulation, including hyperreflexia and panic states, which is typically followed by fatigue and depression.
  • Life-threatening manifestations documented for similar compounds include fatal poisoning, which usually terminates in convulsions and coma.
  • Management is strictly symptomatic and supportive, using procedural steps like gastric lavage and sedation; no specific antidote is known.
  • The official labeling recommends prescribing the least amount feasible at one time to minimize the potential for overdosage.

Therapeutic Uses of Phentermine

What Phentermine Treats: Main Uses and Benefits

Phentermine is generally used for short-term symptomatic assistance in the management of exogenous obesity. This is commonly used across conditions characterized by periods of heightened symptoms that include significant symptomatic burden and related health risks.

The core indications include managing the symptoms of excessive appetite drive and difficulty achieving the feeling of fullness (satiety). This medication is applied across therapeutic domains where additional symptomatic support is needed to address symptoms that create noticeable physiological strain and impede required dietary management.

“This supportive relief contributes to improved comfort during periods of heightened symptoms associated with initial dietary restriction.”

This support may help patients cope more steadily with difficult episodes of initiating significant lifestyle changes, which are relevant to the therapeutic domain of weight reduction. In these clinical scenarios, the medication assists with maintaining functional stability and provides support that helps ease the overall symptom burden.

Quick Fact: Support for Symptoms Related to Appetite
Primary Symptom Domain Excessive Hunger and Lack of Satiety
Typical Use Context Applied in clinical settings that involve an intensive behavioral and dietary change plan
Core Patient Benefit Supports patients during difficult episodes related to dietary adherence

Regulatory References

  1. authoritative guidance from the National Library of Medicine via DailyMed Drug Labeling

Eligibility and Restrictions for Use

Who Can and Cannot Use Phentermine?

The population eligibility for phentermine is strictly defined by regulatory documents, distinguishing between groups permitted to use the medication and those for whom use is absolutely contraindicated.

Eligibility Scope

Eligibility Status Key Regulatory Criteria
Allowed Population Adults and adolescents 16 years of age and older who meet specific BMI criteria for exogenous obesity.
Absolute Contraindication Patients with a history of cardiovascular disease (e.g., uncontrolled hypertension, coronary artery disease, stroke), hyperthyroidism, glaucoma, agitated states, or a history of drug abuse.

Restrictions and Limitations

Official labeling contraindicates the use of phentermine during both pregnancy and lactation. The medication is also prohibited for use during or within 14 days following the administration of Monoamine Oxidase Inhibitors (MAOIs). Use is not recommended in children 16 years of age and younger as safety and effectiveness have not been established in this pediatric population. Caution is advised for geriatric patients and those with severe renal impairment.

What should I know about interactions with other medicines?

Formal Contraindications and Restrictions

The official interaction profile for Phentermine establishes several mandatory restrictions and potential outcomes with co-administered substances. Use is formally contraindicated with Monoamine Oxidase Inhibitors (MAOIs) due to the documented risk of a hypertensive crisis, requiring that administration not occur during or within 14 days following the use of an MAOI. Furthermore, co-administration is not recommended with Fenfluramine, Dexfenfluramine, or other drug products for weight loss (including herbal and over-the-counter agents), as the safety and efficacy of these combinations are not established. Concomitant use with alcohol may result in an adverse drug reaction.


Pharmacodynamic and Requirement Alterations

Phentermine may decrease the hypotensive effect of co-administered Adrenergic Neuron Blocking Drugs, which is a documented pharmacodynamic alteration. For patients with diabetes, requirements for Insulin and Oral Hypoglycemic Medications may be altered due to the physiological changes from the drug's primary effect. Regarding administration timing, the drug can be taken with or without food.


Population-Specific Constraints

A population-specific constraint exists for those with Severe Renal Impairment (eGFR 15 to 29 mL/min/1.73 m^2), where the recommended dosage must be limited to 15 mg daily.

Mechanism of Action

How Phentermine Works: Mechanism of Action

Phentermine operates primarily within the central nervous system through the modulation of monoaminergic signaling. The drug acts as a releasing agent by promoting the non-vesicular expulsion of norepinephrine and, to a lesser extent, dopamine from presynaptic nerve terminals. Concurrently, it functions as a reuptake inhibitor by blocking the action of their respective membrane transporters (NET and DAT). This dual interaction significantly increases the concentration of these neurotransmitters within the synaptic clefts.

The resulting elevated signaling preferentially activates adrenergic receptors located in the hypothalamus. This activation engages regulatory circuits associated with satiety, initiating a cascade that influences hypothalamic pathways governing food intake regulation. Furthermore, the mechanism extends to the broader Sympathetic Nervous System (SNS), consistent with its sympathomimetic action. This systemic activity leads to changes in physiological functions such as increased heart rate and modulation of overall energy expenditure.

Dosage and Administration Information

How to Use Phentermine: Administration Guidelines

Phentermine is an anorectic agent intended strictly for oral administration. The medicine is used on a short-term basis, typically limited to a few weeks, and its continuation depends on the patient's response to the usage protocol. If the appetite-suppressing effect diminishes (tolerance develops), the drug should be discontinued.

Standard Dosing and Frequency

The most common labeled regimen involves taking one 37.5 mg phentermine hydrochloride tablet or capsule once daily. Lower strengths, such as the 15 mg or 30 mg capsules, are also approved daily doses. For certain immediate-release tablets, a lower dose of 18.75 mg (a half-tablet) may be administered twice daily. In all cases, the prescribed maximum daily dose should not be exceeded.

Administration Timing and Preparation

The drug is typically administered once daily in the morning, either before breakfast or approximately one to two hours after breakfast. This specific timing is utilized to ensure the drug's action aligns with daytime activity while limiting the potential for a known adverse effect, such as insomnia. For products formulated as extended-release capsules, the medicine must be swallowed whole; it is not to be crushed, broken, or chewed.

Population-Specific Use

There are specific considerations for certain patient groups. Use is not recommended for patients 16 years of age and younger. For individuals with severe renal impairment, a dose reduction is necessary; for example, the maximum dosage is constrained to 15 mg daily for specific ranges of estimated glomerular filtration rate.

Recent Clinical Evidence

Evidence for Short-Term Weight Management

Short-term Randomized Controlled Trials (RCTs), typically lasting 12 weeks or less, were used in research exploring body weight changes over defined time intervals. These studies examined outcomes related to change in body weight and waist circumference in adults enrolled in lifestyle change programs. Findings describe patterns observed in which a higher proportion of participants reached weight loss thresholds—such as a 5% or greater reduction—compared to participants in the placebo groups.


Understanding Study Duration and Follow-Up

The initial research used in regulatory review was derived from these short-term RCTs. This limited observation period is relevant only for short-term changes. Longer-term effects are not fully established through completed RCTs, but research is ongoing. Data from large, long-term observational cohorts have explored patterns of observation for up to two years. Furthermore, a major randomized trial, the LEAP trial (Long-term Evaluation of Phentermine), is currently designed to observe responses over a 24-month time interval.


Research in Specific Patient Groups and Evidence Quality

Phentermine was evaluated in trials that included adults with controlled co-existing conditions, such as stable hypertension or type 2 diabetes. Research examining monotherapy in adolescents (ages 16 and older) is limited, consisting primarily of retrospective studies. The overall evidence base, reflecting patterns observed across the short-term findings studied, is broadly characterized by a Moderate level of research. Longer-term evidence relies on observational studies, where evidence quality varies.


What Remains Unclear or Unstudied

The core evidence is subject to limitations because the follow-up durations were limited in the primary randomized trials, which contrasts with the chronic nature of obesity. Long-term effects are not fully established. There is limited information for long-term outcomes regarding the monotherapy’s impact on major cardiovascular events. Comparative evidence remains limited for head-to-head RCTs comparing phentermine monotherapy with some newer weight management medications. Research provides context but not individual predictions.

Key Studies & References

  1. Label: PHENTERMINE HYDROCHLORIDE tablet - DailyMed (Monotherapy Information)
  2. Safety and effectiveness of longer-term phentermine use: clinical outcomes from an electronic health record cohort
  3. Long-term Effectiveness of the Antiobesity Medication Phentermine (LEAP) Trial: Study Details | ClinicalTrials.gov

Frequently Asked Questions (FAQ)

Common questions about Phentermine (FAQ)


Q: How quickly can someone expect to see weight loss results from Phentermine?

Clinical trials indicate that the initial rate of weight loss is generally highest during the first few weeks of therapy. Phentermine is intended to be used only on a short-term basis as part of a weight reduction program.

Q: What are the most commonly reported side effects when starting Phentermine?

Official prescribing information notes that adverse reactions may involve several body systems. Commonly reported effects are related to the Central Nervous System (such as restlessness, insomnia, or dizziness), the Cardiovascular system (such as increased heart rate or blood pressure), and the Gastrointestinal tract (such as dry mouth or constipation).

Q: What happens if I forget to take my daily dose of Phentermine?

According to official patient information, if a dose is missed, it should generally be taken as soon as remembered. Taking the medication late in the evening should be avoided, as this is noted in the official label to prevent potential insomnia.

Q: Is it necessary to follow a specific diet while taking Phentermine?

Official documentation indicates the drug is intended to be used only as a supplement to a comprehensive weight management regimen. This regimen includes exercise, behavioral modification, and a calorie-restricted diet, as stated in the drug's indication.

Q: What happens when you stop taking Phentermine?

Abrupt cessation after prolonged use or use at high dosages has been noted in official safety information as potentially leading to withdrawal effects. These effects have been reported to include symptoms like extreme fatigue and mental depression.

Q: What are the signs that Phentermine is starting to work?

The drug is classified as an 'anorectic' agent, and its action is related to appetite suppression. This suppression is a primary intended effect of the medication, which helps support the reduction of caloric intake.

Q: Can Phentermine affect mood or cause mood swings?

Adverse reactions listed in regulatory documents include central nervous system effects such as overstimulation and restlessness. In addition to these common effects, the label notes that manifestations of chronic, severe intoxication may involve psychosis.

Q: What is the difference in effect between Phentermine 15mg and 37.5mg?

Official administration guidelines state that the dosage should be individualized to achieve a sufficient response at the lowest effective dose. Different strengths, such as 15 mg and 37.5 mg, are available to allow prescribers to tailor the medication to the patient’s specific needs.

Q: Are there specific vitamins or supplements that interact negatively with Phentermine?

Official product information states that the co-administration of Phentermine with herbal products for weight loss is not recommended. This is because the safety and effectiveness of such combinations have not been established.

Q: What is the best time of day to take Phentermine?

Official labeling states the drug is typically administered once daily in the morning, either before breakfast or one to two hours after breakfast. This timing is designed to align the effects with daytime activity and minimize the risk of insomnia.

Q: Can drinking caffeine while on Phentermine be dangerous?

Phentermine is classified as a stimulant that can affect the cardiovascular system, raising heart rate and blood pressure. Because caffeine is also a stimulant, combining the two may lead to additive stimulant effects that should be considered.

Q: Do you need to stop Phentermine gradually, or can you just stop?

Official information mentions that withdrawal effects may occur with abrupt cessation of high dosages after prolonged use. This information suggests that the cessation plan should be managed based on the individual’s regimen.

Q: Does alcohol interact with Phentermine?

Yes, official safety labeling specifically notes that the concomitant use of alcohol with Phentermine may result in an adverse drug reaction. The official label notes that use of alcohol is associated with an adverse drug reaction, which is the basis for caution.

Q: Does the appetite suppression effect of Phentermine last all day?

The drug is typically taken once daily in the morning to align its effects with the patient's daytime activity and to minimize the risk of insomnia at night. The duration of the appetite-suppression effect is meant to cover the waking hours but is not explicitly defined as lasting 'all day' in the regulatory material.

Q: How does Phentermine differ from non-stimulant weight loss aids?

Phentermine is classified in official documents as a sympathomimetic amine and a central nervous system (CNS) stimulant. This classification distinguishes its mechanism from non-stimulant treatments for weight management.

Q: Can Phentermine affect your ability to drive or operate machinery?

Regulatory warnings state that Phentermine may impair the ability of a person to engage in potentially hazardous activities. For this reason, official warnings state that caution should be exercised before engaging in activities like driving a motor vehicle or operating machinery.

Q: Is Phentermine used for purposes other than weight loss?

Official prescribing information indicates that the medication is labeled for use exclusively as a short-term adjunct for the management of exogenous obesity.

Q: How long does it take for Phentermine to be eliminated from the body?

According to the clinical pharmacology section of the label, the elimination half-life of Phentermine—the time it takes for half of the drug to be eliminated from the body—is approximately 20 to 25 hours.

Q: Can Phentermine cause changes in taste?

Yes, an alteration in taste is listed among the possible adverse reactions. The official safety information includes a gastrointestinal effect described as an unpleasant taste.

Q: Does Phentermine work equally well for all body mass index (BMI) levels?

The drug is indicated for use in patients who meet specific criteria for obesity. This includes a starting Body Mass Index (BMI) of 30 kg/m^2 or greater, or 27 kg/m^2 or greater if other risk factors are present.

How should Phentermine be stored and disposed of?

Storing and Disposing of Phentermine

Phentermine must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with temporary excursions permitted up to 30 C (86 F). The product requires protection from excess light and moisture, and must be kept in a tight, light-resistant container to maintain stability.

Due to its status as a controlled substance, official labeling requires the medication to be kept in a safe place and strictly out of the reach of children.

For disposal, unused or expired phentermine should be managed through an official drug take-back program. If this option is not available, the medication must be mixed with an unappealing substance, placed in a sealed container, and then discarded in the household trash, as specified in regulatory disposal guidelines. Phentermine should not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Phentermine found in:

A-Z Index: